CLOS
GCVRZ

Compagnie Lombard Odier SCmA’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-84
Closed – – 754
2017
Q3 		$0 Hold
84
– – ﹤0.01% 757
2017
Q2 		$0 Hold
84
– – ﹤0.01% 787
2017
Q1 		$0 Sell
84
-1,000,000
-100% -$439K ﹤0.01% 922
2016
Q4 		$380K Hold
1,000,084
– – 0.01% 362
2016
Q3 		$267K Hold
1,000,084
– – 0.01% 435
2016
Q2 		$240K Hold
1,000,084
– – 0.01% 453
2016
Q1 		$114K Hold
1,000,084
– – ﹤0.01% 597
2015
Q4 		$113K Hold
1,000,084
– – ﹤0.01% 575
2015
Q3 		$190K Hold
1,000,084
– – 0.01% 419
2015
Q2 		$700K Hold
1,000,084
– – 0.03% 258
2015
Q1 		$678K Buy
1,000,084
+1,000,000
+1,190,476% +$699K 0.03% 272
2014
Q4 		$0 Hold
84
– – ﹤0.01% 928
2014
Q3 		$0 Hold
84
– – ﹤0.01% 924
2014
Q2 		$0 Hold
84
– – ﹤0.01% 927
2014
Q1 		$0 Hold
84
– – ﹤0.01% 926
2013
Q4 		$0 Buy
+84
New +$102 ﹤0.01% 848

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Compagnie Lombard Odier SCmA's GCVRZ Position: Q4 2017 in Review

Compagnie Lombard Odier SCmA sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 84 shares.

Compagnie Lombard Odier SCmA first reported a position in GCVRZ in Q4 2013 and held it in 16 quarters. The position peaked at $700K in Q2 2015. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 84 Sanofi Contingent Value Rights shares in Q4 2017.
  • Compagnie Lombard Odier SCmA first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 16 quarters.
  • Compagnie Lombard Odier SCmA's Sanofi Contingent Value Rights position peaked at $700K in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2017, filed 13 Feb 2018.